Physiological hyperglycemia generates increased levels of reactive oxygen species (ROS) from mononuclear cells, which then activate the release of tumor necrosis factor alpha (TNF-α) and increase inflammatory transcription factor NF-kappa B. As a result, the concentrations of TNF-α, a known mediator of insulin resistance, are further increased. The gene discussed is TNF; the disease is Hyperglycemia.